68.6 F
Washington D.C.
Tuesday, September 27, 2022
spot_img

Ebola Vaccine Studies Progress as Marketing Quells Suspicions of Modern Medicine

Ebola had just killed thousands of people in Liberia, and the US-backed pitch to sign locals up for a vaccine trial must have seemed like a tough sell: Take part of the very virus that had devastated the region, combine it with a separate, harmless virus, and inject it into volunteers with the hope they develop Ebola antibodies.

Read complete report here.

Homeland Security Todayhttp://www.hstoday.us
The Government Technology & Services Coalition's Homeland Security Today (HSToday) is the premier news and information resource for the homeland security community, dedicated to elevating the discussions and insights that can support a safe and secure nation. A non-profit magazine and media platform, HSToday provides readers with the whole story, placing facts and comments in context to inform debate and drive realistic solutions to some of the nation’s most vexing security challenges.

Related Articles

- Advertisement -

Latest Articles